nach oben

Environmental Health and Preventive Medicine

Erschienen in:

01.09.2009 | Regular Article

A cross-sectional relationship between vital capacity and metabolic syndrome and between vital capacity and diabetes in a sample Japanese population

verfasst von: Eiji Oda, Ryu Kawai

Erschienen in: Environmental Health and Preventive Medicine | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Objectives

A lower vital capacity (VC) has been reported to be an independent predictor of diabetes in Western countries. The aim of this study was to examine the relationships between VC and diabetes and between VC and metabolic syndrome (MS) in Japanese individuals.

Methods

Stepwise multiple linear regressions with fasting glucose as a dependent variable and age, metabolic risk factors, and percentage vital capacity (%VC) as independent variables were performed using data obtained from 1651 men and 957 women. Area under the receiver operating characteristic curve (AUC) of −%VC for diagnosing diabetes, MS, and Japanese MS (JMS) were calculated, and stepwise logistic regressions using diabetes, MS, and JMS as dependent variables were performed.

Results

Percentage vital capacity was independently associated with fasting glucose in men, but not in women. The AUC of −%VC for diagnosing diabetes, MS, and JMS were 0.647, 0.606, and 0.598, respectively (all p < 0.0001) in men and 0.639 (p = 0.065), 0.513 (p = 0.732), and 0.668 (p = 0.01), respectively, in women. Age, waist circumference (WC), and %VC in men and WC and %VC in women were independently associated with diabetes. Age and %VC in men and only age in women were independently associated with MS, and age and %VC in both men and women were independently associated with JMS.

Conclusions

Among a representative Japanese population, a lower VC was significantly associated with diabetes and MS in men, but the relationships were not conclusive in women.

Alverti KGMM, Zimmet P, Shaw J. Metabolic syndrome: a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469–80.CrossRef

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: a statement for health care professionals: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–52.PubMedCrossRef

Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28:2289–304.PubMedCrossRef

Oda E. The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res. 2008;31:1285–93.CrossRef

Tozawa M, Iseki C, Tokashiki K, Chinen S, Kohagura K, Kinjo K, et al. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res. 2007;30:937–43.PubMedCrossRef

Kawamoto R, Kohara K, Tabara Y, Miki T. An association between metabolic syndrome and the estimated glomerular filtration rate. Intern Med. 2008;47:1399–406.PubMedCrossRef

Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet. 2007;370:797–9.PubMedCrossRef

Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thrommb Vasc Biol. 2008;28:27–38.CrossRef

Lazarus R, Sparrow D, Weiss ST. Baseline ventilator function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: the Normative Aging Study. Eur Respir J. 1998;12:641–5.PubMedCrossRef

10.

Engstrom G, Janzon L. Risk of developing diabetes is inversely related to lung function: a population-based cohort study. Diabet Med. 2002;19:167–70.PubMedCrossRef

11.

Engstrom G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med. 2003;253:574–81.PubMedCrossRef

12.

Ford ES, Mannino DM. Prospective association between lung function and the incidence of diabetes. Findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care. 2004;27:2966–70.PubMedCrossRef

13.

Yeh H, Punjabi NM, Wang N, Pankow JS, Duncan BB, Brancati FL. Vital capacity as a predictor of incident type 2 diabetes. The Atherosclerosis Risk in Communities Study. Diabetes Care. 2005;28:1472–9.PubMedCrossRef

14.

Sakuta H, Suzuki T, Yasuda H, Ito T. Vital capacity and selected metabolic diseases in middle-aged Japanese men. Can Respir J. 2006;13:79–82.PubMed

15.

Nakajima K, Kubouchi Y, Muneyuki T, Ebata M, Eguchi S, Munakata H. A possible association between suspected restrictive patter as assessed by ordinary pulmonary function test and the metabolic syndrome. Chest. 2008;134:712–8.PubMedCrossRef

16.

Fimognari FL, Pasqualetti P, Moro L, Franco A, Piccirillo G, Pastorelli R, et al. The association between metabolic syndrome and restrictive ventilatory dysfunction in older persons. J Gerontol. 2007;62:760–5.

17.

Fernandez-Real JM, Chico B, Shiratori M, Nara Y, Takahashi H, Ricart W. Circulating surfactant protein A (SP-A), a marker of lung injury, is associated with insulin resistance. Diabetes Care. 2008;31:958–63.PubMedCrossRef

18.

The Examination Committee for Criteria of Metabolic Syndrome. Definition and criteria of metabolic syndrome (in Japanese). J Jpn Soc Intern Med. 2005;94:794–809.

19.

Kadota A, Hozawa A, Okamura T, Kadowaki T, Nakamura K, Murakami Y, et al. Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity: NIPPON DATA 90, 1999–2000. Diabetes Care. 2007;30:1533–8.PubMedCrossRef

20.

Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–607.PubMedCrossRef

21.

Katagiri H, Yamada T, Oka Y. Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals. Circ Res. 2007;101:27–39.PubMedCrossRef

22.

Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes. 2002;51:1005–15.PubMedCrossRef

23.

Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005;111:1448–54.PubMedCrossRef

24.

Kim J, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction. Molecular and pathophysiological mechanisms. Circulation. 2006;113:1888–904.PubMedCrossRef

25.

Sattar N, McConnachie A, Shaper G, Blauw G, Buckley BM, de Craen AJ, et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008;371:1927–35.PubMedCrossRef

26.

Brantsma AH, Bakker SJL, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT, and the PREVEND Study Group. Urinary albumin excretion and its relation with C-reactive protein and metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care. 2005;28:2525–30.PubMedCrossRef

27.

Chance WW, Rhee C, Yilmaz C, Dane DM, Pruneda ML, Raskin P, et al. Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy. Diabetes Care. 2008;31:1596–601.PubMedCrossRef

28.

Oda E, Kawai R. A tentative cut point of high-sensitivity C-reactive protein for a component of metabolic syndrome in Japanese. Circ J. 2009;73:755–9.PubMedCrossRef

29.

Regazzetti C, Peraldi P, Gremeaux T, Najem-Lendom R, Ben-Sahra I, Cormont M, et al. Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes. 2009;58:95–103.PubMedCrossRef

30.

Lazarus R, Sparrow D, Weiss ST. Hand-grip strength and insulin levels: cross-sectional and prospective associations in the Normative Aging Study. Metabolism. 1997;46:1266–9.PubMedCrossRef

Titel: A cross-sectional relationship between vital capacity and metabolic syndrome and between vital capacity and diabetes in a sample Japanese population
verfasst von: Eiji Oda
Ryu Kawai
Publikationsdatum: 01.09.2009
Verlag: Springer Japan
Erschienen in: Environmental Health and Preventive Medicine / Ausgabe 5/2009
Print ISSN: 1342-078X
Elektronische ISSN: 1347-4715
DOI: https://doi.org/10.1007/s12199-009-0098-5

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

A cross-sectional relationship between vital capacity and metabolic syndrome and between vital capacity and diabetes in a sample Japanese population

Abstract

Objectives

Methods

Results

Conclusions

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2009

Low serum secretory immunoglobulin A level and sense of coherence score at an early gestational stage as indicators for subsequent threatened premature birth

The relationship between clustering health-promoting components of lifestyle and bone status among middle-aged women in a general population

Relationship between the Noto-Peninsula earthquake and maternal postnatal depression and child-rearing

Metallomics study using hair mineral analysis and multiple logistic regression analysis: relationship between cancer and minerals

Abstracts from Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene) vol. 64 no. 3

Monitoring of environmental contamination by Echinococcus multilocularis in an urban fringe forest park in Hokkaido, Japan